Jiayuan Science and Technology Co.,Ltd. (SHE:301117)
China · Delayed Price · Currency is CNY 25.32
+0.59 (2.39%)
At close: Jun 12, 2026
SHE:301117 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 325.05 | 318.69 | 321.93 | 227.39 | 269.52 | 316.84 |
Other Revenue | 1.2 | 1.2 | 14.87 | - | - | - |
| 326.24 | 319.88 | 336.8 | 227.39 | 269.52 | 316.84 | |
Revenue Growth (YoY) | -4.78% | -5.02% | 48.11% | -15.63% | -14.94% | 66.27% |
Cost of Revenue | 263.1 | 249.16 | 191.57 | 118.08 | 120.02 | 147.6 |
Gross Profit | 63.15 | 70.72 | 145.23 | 109.31 | 149.5 | 169.24 |
Selling, General & Admin | 55.9 | 57.13 | 61.25 | 57.13 | 35.38 | 21.15 |
Research & Development | 61.54 | 62.35 | 63.07 | 63.22 | 50.23 | 28.8 |
Other Operating Expenses | 0.87 | 0.81 | 1.66 | 1.01 | -0.68 | 2.44 |
Operating Expenses | 135.73 | 132.01 | 148.41 | 133.37 | 94.59 | 63.96 |
Operating Income | -72.58 | -61.29 | -3.18 | -24.06 | 54.9 | 105.28 |
Interest Expense | -2.28 | -2.15 | -0.82 | -0.33 | -1.36 | -2 |
Interest & Investment Income | 2.42 | 3.54 | 9.22 | 15.02 | 17.41 | 0.1 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.03 | -0.02 | - | - |
Other Non Operating Income (Expenses) | -0.99 | -0.15 | -0.16 | -0.78 | 0.02 | -1.65 |
EBT Excluding Unusual Items | -73.43 | -60.04 | 5.07 | -10.18 | 70.97 | 101.72 |
Impairment of Goodwill | - | - | -2.76 | - | - | - |
Gain (Loss) on Sale of Investments | 4.65 | 4.65 | 0.07 | 1.22 | - | - |
Gain (Loss) on Sale of Assets | 0.02 | 0.01 | - | -0 | -0 | - |
Asset Writedown | -0.16 | - | -0.22 | - | - | - |
Other Unusual Items | 0.97 | 0.98 | 5.47 | -0.14 | -4.06 | 4.7 |
Pretax Income | -67.95 | -54.4 | 7.63 | -9.1 | 66.9 | 106.42 |
Income Tax Expense | -15.91 | -11.92 | -3.54 | -3.31 | 5.5 | 13.33 |
Earnings From Continuing Operations | -52.03 | -42.48 | 11.17 | -5.79 | 61.4 | 93.09 |
Minority Interest in Earnings | -0.68 | -0.47 | 0.27 | 0.43 | 0.17 | -0.59 |
Net Income | -52.71 | -42.95 | 11.45 | -5.35 | 61.57 | 92.5 |
Net Income to Common | -52.71 | -42.95 | 11.45 | -5.35 | 61.57 | 92.5 |
Net Income Growth | - | - | - | - | -33.43% | 75.68% |
Shares Outstanding (Basic) | 195 | 182 | 178 | 175 | 177 | 135 |
Shares Outstanding (Diluted) | 195 | 182 | 178 | 175 | 177 | 135 |
Shares Change (YoY) | 19.09% | 2.37% | 1.75% | -1.45% | 31.19% | -0.35% |
EPS (Basic) | -0.27 | -0.24 | 0.06 | -0.03 | 0.35 | 0.68 |
EPS (Diluted) | -0.27 | -0.24 | 0.06 | -0.03 | 0.35 | 0.68 |
EPS Growth | - | - | - | - | -49.26% | 76.30% |
Free Cash Flow | -110.16 | -126.18 | -177.96 | -97.79 | -226.3 | -53.17 |
Free Cash Flow Per Share | -0.56 | -0.69 | -1.00 | -0.56 | -1.27 | -0.39 |
Dividend Per Share | - | - | 0.014 | - | 0.076 | 0.204 |
Dividend Growth | - | - | - | - | -62.52% | - |
Gross Margin | 19.36% | 22.11% | 43.12% | 48.07% | 55.47% | 53.41% |
Operating Margin | -22.25% | -19.16% | -0.95% | -10.58% | 20.37% | 33.23% |
Profit Margin | -16.16% | -13.43% | 3.40% | -2.35% | 22.85% | 29.20% |
Free Cash Flow Margin | -33.77% | -39.45% | -52.84% | -43.00% | -83.96% | -16.78% |
EBITDA | -39.31 | -31.09 | 14.74 | -18.06 | 55.85 | 106.12 |
EBITDA Margin | -12.05% | -9.72% | 4.38% | -7.94% | 20.72% | 33.50% |
D&A For EBITDA | 33.27 | 30.2 | 17.92 | 6 | 0.95 | 0.85 |
EBIT | -72.58 | -61.29 | -3.18 | -24.06 | 54.9 | 105.28 |
EBIT Margin | -22.25% | -19.16% | -0.95% | -10.58% | 20.37% | 33.23% |
Effective Tax Rate | - | - | - | - | 8.22% | 12.53% |
Revenue as Reported | 326.24 | 319.88 | 336.8 | 227.39 | 269.52 | 316.84 |
Advertising Expenses | - | - | 0.06 | 0.53 | 0 | - |